… metastatic PCa. To address this void, we sought to evaluate the role of the metastatic site on
survival … Our hypothesis stated that the occurrence of visceral metastases might represent an …

… metastatic prostate cancer followed within the context of a cooperative group phase III clinical
trial for 10 years, we have demonstrated a group of factors that predict long-term survival (…

… that metastatic site is an important predictor of overall survival (OS) in men with metastatic
castration-resistant prostate cancer (… We investigate the impact of site of metastases on OS of a …

… , cancer cells can survive as DTCs at the metastatic site for decades. The dynamics of
metastatic … phenotype survive castration in human prostate cancer. Stem Cells 30: 1076–1086. …

… in an era with new therapies that prolong OS in men with metastatic hormone-sensitive
prostate cancer and castration-resistant prostate cancer; however, because these have a modest …

… In conclusion, among men with nonmetastatic castration-resistant prostate cancer,
metastasis-free survival was significantly longer with apalutamide than with placebo. Consistent …

… The prognosis of patients diagnosed with metastatic prostate cancer seems to be modulated
by factors such as the number and site of metastases. Our objective is to evaluate survival …

… (renal, colon, and ovarian cancer), despite established metastatic spread [1], [2], [3], [4], [5],
[6]. LT may also improve survival in metastatic prostate cancer (mPCa), relative to standard of …

… types it has been demonstrated that the number of metastases is an important … of metastases
on prostate cancer-specific survival (PCSS) in noncastrate patients developing metastases …

… : in a Danish population-based study in men with prostate cancer, one-year survival was 87…
of prostate cancer bone metastases (PCBMs) and the clinical burden of skeletal metastases …